Biovica International
0.35 SEK
+11.82 %
Less than 1K followers
BIOVIC B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Biovica International
| Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | Q1/26 | Q2/26 | Q3/26 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.7 | 2.3 | 2.3 | 2.3 | 8.6 | 2.6 | 2.7 | 3.3 |
| EBITDA | -21.2 | -17.6 | -20.0 | -18.2 | -77.0 | -17.2 | -12.8 | -15.8 |
| EBIT | -23.6 | -19.8 | -22.2 | -20.4 | -85.8 | -19.3 | -15.0 | -17.8 |
| EBIT-% | -1,377.8 % | -855.0 % | -981.4 % | -869.7 % | -995.8 % | -743.5 % | -559.4 % | -539.7 % |
| Profit before taxes | -24.2 | -19.5 | -22.0 | -20.2 | -86.0 | -19.1 | -15.0 | -17.7 |
| Net income | -22.9 | -21.2 | -22.8 | -20.8 | -87.6 | -17.8 | -15.1 | -17.9 |